|
⚲
|
| Keyboard |
| O'Loughlin Steve
✚
|
|
|---|---|
| CIK # | 0001615840 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001615840] | |
| 4 | [0001615840] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| O'Loughlin Steve | |
| CNS Pharmaceuticals Inc | |
| Actinium Pharmaceuticals Inc | |
| Protea Biosciences Group Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
CNS Pharmaceuticals Inc CNSP
Restricted Stock Units · derivative
|
2026-03-02 | Grant | 9,500 | ||
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Disposed to issuer | 3,333 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Disposed to issuer | 1,666 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Disposed to issuer | 3,333 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Disposed to issuer | 8,833 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Disposed to issuer | 13,333 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Disposed to issuer | 59,066 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Disposed to issuer | 107,463 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Disposed to issuer | 253,123 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2025-03-31 | Disposed to issuer | 256,438 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2023-12-28 | Grant | 253,123 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2022-07-01 | Grant | 256,438 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2021-09-01 | Grant | 107,463 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Stock Option (Right to Buy) · derivative
|
2020-08-12 | Grant | 59,066 | $0.00 | |
|
Actinium Pharmaceuticals Inc ATNM
Options to purchase common stock · derivative
|
2019-07-12 | Grant | 400,000 | $0.23 | 92,000 |
|
Actinium Pharmaceuticals Inc ATNM
Common Stock
|
2018-12-10 | Buy | 10,000 | $0.44 | 4,400 |
|
Actinium Pharmaceuticals Inc ATNM
Options to purchase common stock · derivative
|
2018-07-13 | Grant | 265,000 | $0.78 | 206,700 |
|
Actinium Pharmaceuticals Inc ATNM
Common Stock
|
2018-06-15 | Buy | 12,000 | $0.50 | 6,000 |
|
Actinium Pharmaceuticals Inc ATNM
Common Stock
|
2018-03-06 | Other | 10,000 | $0.50 | 5,000 |
|
Actinium Pharmaceuticals Inc ATNM
Series B Warrants · derivative
|
2018-03-06 | Other | 7,500 | $0.50 | 3,750 |
| showing 20 of 22 most recent transactions | |||||